Episode Details

Canada Approves Generic Semaglutide: A Game Changer for Weight Loss and Diabetes Treatment

Canada has just approved its first generic versions of semaglutide, the active ingredient in popular drugs like Ozempic, for Type 2 diabetes and weight management. Dr. Reddys Laboratories and Apotex have received the green light from Health Canada, with some generic versions already available. The patent protection for Novo Nordisks semaglutide expired in January, allowing other companies to produce cheaper alternatives. These generics are expected to be significantly more affordable, potentially reducing the monthly cost to around one hundred dollars for some patients. This move makes Canada the first G7 nation to approve a generic version of this widely used medication, aiming to increase accessibility for a larger population.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/d445c260044ed842